Abstract: Disclosed is a stable liquid formulation, comprising an antibody or antigen-binding portion thereof, an acetate buffer, glycine, and a surfactant, wherein the stable liquid formulation does not comprise at least one of sugar, a sugar alcohol and a metal salt, and the stable liquid formulation is still stable even upon high antibody content, and is superior in osmolality and viscosity, and subcutaneous administration thereof is possible.

Abstract: The present disclosure relates to managing a document to be cleaned, includes processing a request, in response to the request to store document data of a first document in a database, based on at least one of whether the first document is duplicate or whether substantive contents of the first document are a same in a relationship with a second document pre-stored in the database, whether the first document is duplicate may be determined by comparing a unique identification value and version information of the first document with a unique identification value and version information of the second document, and whether substantive contents of the first document are the same may be determined by comparing hash data of the first document with hash data of the second document.

Abstract: A method of an integrated access and backhaul (IAB) node may include: receiving, from a target base station, one or more user equipment (UE) context setup request messages including terminal radio resource reconfiguration information; sharing context information including the terminal radio resource reconfiguration information with a source IAB-distributed unit 1 (IAB-DU1); configuring terminal reconfiguration information using the shared context information; and transmitting one or more UE context setup response messages including the terminal reconfiguration information to the target base station in response to the one or more UE context setup request messages.

Abstract: A method of a terminal, according to an exemplary embodiment of the present disclosure, may include: requesting access to a mobile integrated access backhaul (IAB) based on cell search; receiving a tracking area (TA) update procedure stop request message from an Access and Mobility Management Function (AMF) of a core network; and deactivating a TA update procedure based on the TA update procedure stop request message.

Abstract: A method of an IAB node may comprise: receiving an RRC message including measurement control information from a base station; transmitting RRC reconfiguration information including the measurement control information to each of a plurality of terminals; receiving a measurement report message including a measurement report generated by each of the plurality of terminals based on the measurement control information from each of the plurality of terminals; and grouping the measurement report messages received from the plurality of terminals into a grouped message report message, and transmitting the grouped measurement report message to the base station according to a grouped measurement reporting periodicity.

Abstract: The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.

Abstract: In a method for treating a cancer expressing secreted protein acidic and rich in cysteine (SPARC), a composition including an albumin and at least one cysteine bound thereto is administered to a subject in need thereof. The cancer expressing the SPARC may be at least one selected from the group consisting of a brain tumor, melanoma, breast cancer, rectal cancer and stomach cancer.

Abstract: A method of an aerial vehicle for urban air mobility may include: reporting, to a first base station, a measurement result for neighboring base stations including a second base station; receiving, from the first base station and as a processing result based on the measurement result, an indication of a failure of a handover to the second base station; requesting, to a control station, first location information indicating a first location to move according to the failure of the handover; receiving the first location information from the control station; and moving according to the received first location information.

Abstract: The present disclosure relates to a printed circuit board including, a first insulating layer, a first metal layer disposed on the first insulating layer, a bridge disposed on the first metal layer and including a bridge insulating layer and a bridge circuit layer, a second insulating layer disposed on the first insulating layer and covering at least a portion of the bridge, a second metal layer disposed on the second insulating layer, and a connecting via penetrating the bridge and the second insulating layer to connect the first metal layer to the second insulating layer. The connecting via is spaced apart from the bridge circuit layer.

Abstract: A semiconductor device includes a line; a source structure on the line; a stack structure on the source structure; a first slit structure penetrating the stack structure; a second slit structure penetrating the stack structure; and a contact plug adjacent to the first slit structure in a first direction. The first slit structure and the second slit structure may be spaced apart from each other by a first distance in a second direction that is perpendicular to the first direction. The contact plug penetrates the source structure, the contact plug being electrically connected to the lower line. The first slit structure and the contact plug may be spaced apart from each other by a second distance in the first direction, and the second distance may be longer than the first distance.

Abstract: The present disclosure relates to a plurality of host materials, an organic electroluminescent compound, and an organic electroluminescent device comprising the same. By comprising a specific combination of host compounds and/or an organic electroluminescent compound according to the present disclosure as an organic electroluminescent material, an organic electroluminescent device having low driving voltage and/or high luminous efficiency and/or long lifespan characteristics can be provided.

Abstract: A vehicle diagnosis system, an apparatus therefor, and a method therefore are provided. The vehicle diagnosis system includes a wireless charging station that transmits a message including information related to a supportable service type and information related to a vendor of a supportable vehicle and a vehicle that identifies the message and connect a diagnosis session for diagnosing and reprogramming the vehicle. The diagnosis session is performed when a connection for a wireless charging session of the vehicle is established.

Abstract: A display device includes: a display panel including a pixel array, in which pixels that include a plurality of inorganic light-emitting devices of different colors are arranged in a matrix form, and a pixel circuit that is provided for each of the plurality of inorganic light-emitting devices, and the pixel circuit controls, on the basis of an applied image data voltage, the driving time and the magnitude of driving current provided to the inorganic light-emitting devices; a sensor which senses, on the basis of a voltage applied to the pixel circuit, a current flowing through a driving transistor included in the pixel circuit and which outputs sensing data corresponding to the sensed current; and a corrector which corrects, on the basis of the sensed data, the image data voltage applied to the pixel circuit.

Abstract: The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.

Abstract: A display apparatus includes display panel including a pixel array in which pixels, each of which including a plurality of inorganic light emitting elements, are disposed in a plurality of row lines, and sub pixel circuits corresponding to inorganic light emitting elements of the pixel array, a driving unit configured to set an image data voltage sequentially to the sub pixel circuits based on a first driving voltage, and drive the sub pixel circuits so that a driving current corresponding to the set image data voltage is provided sequentially to the inorganic light emitting elements of the pixel array based on a second driving voltage; a sensing unit configured to sense a current flowing through a driving transistor included in each of the sub pixel circuits based on a specific voltage which is applied to the sub pixel circuits, and output sensing data corresponding to the sensed current; and a correction unit configured to correct an image data voltage to be applied to each of the sub pixel circuits based o

Abstract: The present invention relates to a high voltage-type redox flow battery comprising: a plurality of modules (1001, 1002, 1003, . . , 100n) which are serially connected; and a battery management system (BMS) for monitoring a state-of-charge (SOC) of each of the plurality of modules (1001, 1002, 1003, ..

Abstract: An asphalt binder includes an asphalt and an adhesion promoter composition. The adhesion promoter composition includes a vinyl acetate-ethylene (VAE)-based redispersible polymer and a wetting agent. The wetting agent includes at least one selected from the group consisting of: polyethylene glycol phenyl ether, polyethylene glycol higher alkyl, ether dialkyl sulfosuccinate, alkyl amine, alcohol amine, polyethyleneimine, and sorbitan aliphatic ethylene oxide adduct. Further, the wetting agent is included in an amount ranging from 0.5 to 45 percent by weight (wt %) with respect to the total weight of the adhesion promoter composition.

Abstract: The present invention provides a pharmaceutical composition for prevention or treatment of a stress disease and depression, the pharmaceutical composition be safely useable without toxicity and side effects by using an extract of leaves of Vaccinium bracteatum Thunb., which is natural resource of Korea, so that the reduction of manufacturing and production costs and the import substitution and export effects can be expected through the replacement of a raw material for preparation with a plant inhabiting in nature.

Abstract: Provided is a display apparatus including a modular display panel that includes a plurality of displays disposed in a matrix form and respectively including a display panel including a pixel array in which pixels including a plurality of inorganic light emitting elements are disposed in a plurality of row lines, sub-pixel circuits respectively corresponding to inorganic light emitting elements of the pixel array, a driver configured to drive the sub-pixel circuits, a sensor configured to sense a current flowing in a driving transistor included in the sub-pixel circuits and output sensing data corresponding to the sensed current, and a processor configured to correct the image data voltage applied to the sub-pixel circuits based on the sensing data, and a timing controller configured to provide a first start signal to a driver of a first display and a second start signal to a driver of a second display.

Abstract: The present invention relates to a method for designing a cycloidal gear tooth profile of a gear shift actuator, the method designing a profile to have a backlash through a change in the radius of a rolling circle of an internal or external tooth profile of a cycloidal gear, and thus enables the smooth engagement of internal teeth and external teeth, reduces the engagement range of the internal teeth and the external teeth to have excellent durability and enable power loss to be reduced, and enables the shape machining of the gear by using general cycloidal gear machining, thereby facilitating manufacturing and being capable of improving machining precision.